Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial
Giulia Argentesi(St Bartholomew's Hospital), Mark Gurnell(University of Cambridge), Patrick C. Wilson(Center for Rheumatology), Edmund Godfrey(Addenbrooke's Hospital), Jessica Kearney(St Bartholomew's Hospital), Alison Marker(Cambridge University Hospitals NHS Foundation Trust), George Goodchild(St Bartholomew's Hospital), James MacFarlane(University of Cambridge), Alexander Ney(University College Hospital), Elena Daniela Benu, Kate Laycock(St Bartholomew's Hospital), Emily Goodchild(St Bartholomew's Hospital), Jackie Salsbury(Queen Mary University of London), Russell Senanayake(University of Cambridge), Razeen Mahroof, José Mesquita Bastos, August Palma, Jonathan P. Bestwick(Queen Mary University of London), Stephen P. Pereira(University College London Hospitals NHS Foundation Trust), Daniel Gillett(Cambridge University Hospitals NHS Foundation Trust), Elisabeth Ng(Queen Mary University of London), Xi‐Lin Wu(Queen Mary University of London), Yun-Ni Lee(St Bartholomew's Hospital), John A. Tadross(University of Cambridge), Sam O’Toole(Royal Hallamshire Hospital), Morris J. Brown(Queen Mary University of London), William M Drake(St Bartholomew's Hospital), Iulia Munteanu, Heok Cheow(Cambridge University Hospitals NHS Foundation Trust), Patrizia Ebano, Nick Carroll(Addenbrooke's Hospital)
Cited by 25
Related Papers
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874